Latest Breaking News On - Sam banister - Page 1 : vimarsana.com

Japanese Pharma Company Sponsors Australian Start Up In Development Of Non-Hallucinogenic Medicines - Daiichi Sankyo Co (OTC:DSNKY)

Australia biotech startup Psylo has inked a sponsored research agreement with global Japanese pharmaceutical company Daiichi Sankyo (OTCMKTS: DSNKY) toward advancing antidepressant psychiatric medicines.

United statesMatthew burkhardtDaiichi sankyoJosh isminSam banisterBuilding australiaPsychedelics industry

PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES

PSYLO ANNOUNCES SPONSORED RESEARCH AGREEMENT WITH DAIICHI SANKYO TO DEVELOP NON-HALLUCINOGENIC PSYCHIATRIC THERAPIES
sydneysun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sydneysun.com Daily Mail and Mail on Sunday newspapers.

United statesNew south walesDaiichi sankyoMatthew burkhardtSam banisterJosh isminResearch agreementSponsored research agreementChief scientific officer

The race to patent psychedelic drugs

As the psychedelic medicine gold rush accelerates, there are ways to game the system and some companies are testing the limits of patent law.

South australiaMartin williamsSam banisterDanny gelmanMultidisciplinary association for psychedelic studiesUs patent officeAustralian patent officeUsona instituteMonash universityHarvard law schoolMind medicine australiaMultidisciplinary associationPsychedelic studiesCosmos weeklyCompass pathways

Australia approves psychedelics for depression, PTSD: Emyria, Reset Mind Services, Psylo scramble

Biotechs backed by billionaires Andrew Forrest and Gina Rinehart are racing to get psychedelic therapies ready to market after Australia became only the second country after Canada to approve their use to treat depression and PTSD.

Steve burnellJosh isminTony mcdonoughSam banisterAnne rustonShaun duffyEli kotlerReset mindPeter huntMind medicines australia

Mental health and psychedelics: Sector races for legitimacy as the Therapeutic Goods Administration takes a cautious stance

Around Australia and the world, scientists, psychiatrists and CEOs are mapping out the potential of psychedelics. But not everyone’s on the same page.

Wood mallesonsJosh isminTony mcdonoughSam banisterJames alcockPeter huntAgnieszka sekulaShaun duffyMichael winloEmyria michael winloCreso incannexPrash puspanathanSuzy madarKing wood mallesonsSwinburne universityPsychedelic society of belgium